Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,019 Cr
up ₹68 Cr vs Feb 2025
- Stocks held
- 30
- down 1 vs Feb 2025
- Top 10 weight
- 64.4%
- of the portfolio in its ten largest
- Cash & debt
- 0.8%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 11
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In March 2025 it disclosed 30 stocks worth ₹3,019 Cr, up ₹68 Cr from Feb 2025. Its largest positions were Sun Pharmaceutical Industries Limited (10.8%), Suven Pharmaceuticals Limited (9.5%), Cipla Limited (8.6%); the ten largest together made up 64.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.4% of its equity. Cash and debt stood at 0.8%. Compared with Feb 2025 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
12%
Holds more cash than 12% of peers
Holdings in March 2025
Download CSVEvery line the fund disclosed, with the change against Feb 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 10.78%
- Δ weight
- up 0.65 pts
- Value
- ₹325 Cr
- Δ value
- up ₹26.5 Cr
- Status
- Added
- Weight
- 9.49%
- Δ weight
- down 0.76 pts
- Value
- ₹287 Cr
- Δ value
- down ₹15.9 Cr
- Status
- Trimmed
- Weight
- 8.55%
- Δ weight
- up 0.01 pts
- Value
- ₹258 Cr
- Δ value
- up ₹6.2 Cr
- Status
- Added
- Weight
- 7.98%
- Δ weight
- up 0.61 pts
- Value
- ₹241 Cr
- Δ value
- up ₹23.5 Cr
- Status
- Added
- Weight
- 5.58%
- Δ weight
- down 0.82 pts
- Value
- ₹168 Cr
- Δ value
- down ₹20.3 Cr
- Status
- Trimmed
- Weight
- 4.86%
- Δ weight
- up 0.01 pts
- Value
- ₹147 Cr
- Δ value
- up ₹3.6 Cr
- Status
- Added
- Weight
- 4.51%
- Δ weight
- up 0.54 pts
- Value
- ₹136 Cr
- Δ value
- up ₹19.1 Cr
- Status
- Added
- Weight
- 4.38%
- Δ weight
- up 0.80 pts
- Value
- ₹132 Cr
- Δ value
- up ₹26.5 Cr
- Status
- Added
- Weight
- 4.27%
- Δ weight
- up 0.27 pts
- Value
- ₹129 Cr
- Δ value
- up ₹11 Cr
- Status
- Added
- Weight
- 4.03%
- Δ weight
- up 0.29 pts
- Value
- ₹122 Cr
- Δ value
- up ₹11.3 Cr
- Status
- Added
- Weight
- 3.61%
- Δ weight
- down 0.61 pts
- Value
- ₹109 Cr
- Δ value
- down ₹15.5 Cr
- Status
- Trimmed
- Weight
- 3.40%
- Δ weight
- up 0.24 pts
- Value
- ₹103 Cr
- Δ value
- up ₹9.3 Cr
- Status
- Added
- Weight
- 2.83%
- Δ weight
- down 0.17 pts
- Value
- ₹85.6 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 2.73%
- Δ weight
- up 0.24 pts
- Value
- ₹82.3 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 2.71%
- Δ weight
- down <0.01 pts
- Value
- ₹81.7 Cr
- Δ value
- up ₹1.8 Cr
- Status
- Added
- Weight
- 2.66%
- Δ weight
- down 0.09 pts
- Value
- ₹80.3 Cr
- Δ value
- down ₹93 L
- Status
- Trimmed
- Weight
- 2.64%
- Δ weight
- down 0.55 pts
- Value
- ₹79.5 Cr
- Δ value
- down ₹14.5 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- up 0.34 pts
- Value
- ₹75.3 Cr
- Δ value
- up ₹11.8 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- up 0.22 pts
- Value
- ₹58.8 Cr
- Δ value
- up ₹7.8 Cr
- Status
- Added
- Weight
- 1.80%
- Δ weight
- up 0.23 pts
- Value
- ₹54.3 Cr
- Δ value
- up ₹8 Cr
- Status
- Added
- Weight
- 1.43%
- Δ weight
- up 0.05 pts
- Value
- ₹43.3 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 1.22%
- Δ weight
- up 0.08 pts
- Value
- ₹36.8 Cr
- Δ value
- up ₹3.1 Cr
- Status
- Added
- Weight
- 1.19%
- Δ weight
- down 0.10 pts
- Value
- ₹35.9 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- down 0.05 pts
- Value
- ₹29 Cr
- Δ value
- down ₹94 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.82%
- Δ weight
- down 0.91 pts
- Value
- ₹24.8 Cr
- Δ value
- down ₹26.2 Cr
- Status
- Trimmed
- Weight
- 0.60%
- Δ weight
- up 0.02 pts
- Value
- ₹18.2 Cr
- Δ value
- up ₹88 L
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.55%
- Δ weight
- down 0.12 pts
- Value
- ₹16.7 Cr
- Δ value
- down ₹3.1 Cr
- Status
- Trimmed
- Weight
- 0.52%
- Δ weight
- down 0.02 pts
- Value
- ₹15.6 Cr
- Δ value
- down ₹18 L
- Status
- Trimmed
- Weight
- 0.51%
- Δ weight
- up 0.04 pts
- Value
- ₹15.4 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 0.48%
- Δ weight
- up 0.02 pts
- Value
- ₹14.6 Cr
- Δ value
- up ₹87 L
- Status
- Added
- Weight
- 0.41%
- Δ weight
- up 0.09 pts
- Value
- ₹12.5 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 0.06%
- Δ weight
- down 0.04 pts
- Value
- ₹1.9 Cr
- Δ value
- down ₹1 Cr
- Status
- Trimmed
What changed, Feb 2025 to Mar 2025
New New positions (0)
None.
Exited Exited (1)
- Lupin Limitedwas 0.5% · ₹15.3 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹26.5 Cr (+0.65% pts)
- Alembic Pharmaceuticals Limitedup ₹26.5 Cr (+0.80% pts)
- IPCA Laboratories Limitedup ₹23.5 Cr (+0.61% pts)
- Laurus Labs Limitedup ₹19.1 Cr (+0.54% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Feb 2025, the weight rose most in Pharmaceuticals & Biotechnology (+1.2 pts) and Pharmaceuticals (+0.4 pts), and fell most in Healthcare Equipment & Supplies (−1.4 pts) and Healthcare Services (−0.2 pts).
- Pharmaceuticals & Biotechnology65.2% → 66.4%+1.2 pts
- Pharmaceuticals5.3% → 5.7%+0.4 pts
- Healthcare Equipment & Supplies10.1% → 8.7%−1.4 pts
- Healthcare Services17.5% → 17.2%−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2022 | Mar 2024 | Sep 2024 | Dec 2024 | Feb 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 54.7% | 71.3% | 66.7% | 66.4% | 65.2% | 66.4% |
| Healthcare Services | 27.8% | 13.9% | 17.7% | 17.3% | 17.5% | 17.2% |
| Healthcare Equipment & Supplies | 6.4% | 7.1% | 8.0% | 8.5% | 10.1% | 8.7% |
| Pharmaceuticals | 7.0% | 5.3% | 5.4% | 5.9% | 5.3% | 5.7% |
| Insurance | 2.5% | 1.8% | 1.8% | 1.3% | 1.4% | 1.5% |
| Retailing | 1.5% | 0.6% | 0.4% | 0.5% | 0.5% | 0.5% |
Allocation in Mar 2025change vs Feb 2025
- Pharmaceuticals & Biotechnology (14)66.4%▲ 1.2 pts
- Healthcare Services (8)17.2%▼ 0.2 pts
- Healthcare Equipment & Supplies (3)8.7%▼ 1.4 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2025
0.8%
▼ 0.9 pts vs Feb 2025
- Cash alone
- 0.8%
- cash and net receivables
- A year earlier
- 1.7%
- Mar 2024 · now ▼ 0.9 pts
- Last 12 months
- 0.8% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.